Daily GnRH agonist treatment delays the development of reproductive physiology and behavior in male rats
Sign Up to like & getrecommendations! Published in 2021 at "Hormones and Behavior"
DOI: 10.1016/j.yhbeh.2021.104982
Abstract: The present study was designed to examine the effects of suppressing pubertal onset with leuprolide acetate, a gonadotropin releasing hormone (GnRH) agonist. Starting on postnatal day (PD) 25, male Long-Evans rats were injected daily with… read more here.
Keywords: treatment; gnrh agonist; physiology; agonist treatment ... See more keywords
Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Neurosciences in Rural Practice"
DOI: 10.1055/s-0041-1736509
Abstract: Objectives Illicit opioid use is a major concern across the globe due to its adverse health consequences. Pharmacological intervention is regarded as the cornerstone of management of opioid dependence and the Opioid Agonist Treatment (OAT)… read more here.
Keywords: north india; oat clinic; agonist treatment; use ... See more keywords
Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: Dynamic modeling analysis.
Sign Up to like & getrecommendations! Published in 2019 at "Addiction"
DOI: 10.1111/add.14797
Abstract: BACKGROUND AND AIMS Although opioid agonist treatment (OAT) for opioid use disorder (OUD) is cost-effective in settings where the HIV epidemic is concentrated among people who inject drugs, OAT coverage in Ukraine remains far below… read more here.
Keywords: capacity; oat; treatment; agonist treatment ... See more keywords
Global opioid agonist treatment: A review of clinical practices by country.
Sign Up to like & getrecommendations! Published in 2020 at "Addiction"
DOI: 10.1111/add.15087
Abstract: AIMS We assessed how opioid agonist treatment (OAT) for opioid use disorder (OUD), specifically methadone and buprenorphine, including buprenorphine-naloxone, is delivered in routine clinical practice, with a focus on factors that affect access to and… read more here.
Keywords: buprenorphine; agonist treatment; opioid agonist; global opioid ... See more keywords
Opium tincture versus methadone for opioid agonist treatment: A randomized controlled trial.
Sign Up to like & getrecommendations! Published in 2022 at "Addiction"
DOI: 10.1111/add.16030
Abstract: AIM To test if opium tincture (OT) was non-inferior to methadone in retaining participants in opioid agonist treatment (OAT). DESIGN A phase III, multicentre, parallel group, non-inferiority, double-blind randomized controlled trial with an allocation ratio… read more here.
Keywords: methadone; agonist treatment; treatment; opioid agonist ... See more keywords
Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Endocrinology"
DOI: 10.1111/cen.14714
Abstract: To estimate the proportion of patients with persistent normoprolactinaemia following dopamine agonist (DA) withdrawal and to identify predictors of successful withdrawal in patients with hyperprolactinaemia. read more here.
Keywords: treatment patients; withdrawal; dopamine agonist; agonist treatment ... See more keywords
Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross‐sectional survey of Australian treatment clients
Sign Up to like & getrecommendations! Published in 2022 at "Drug and Alcohol Review"
DOI: 10.1111/dar.13437
Abstract: Abstract Introduction Opioid agonist treatment (OAT) clients frequently bear costs associated with their treatment, including dosing fees. This study aimed to explore the financial and social impact of dosing fees upon clients. Methods Cross‐sectional survey… read more here.
Keywords: cross sectional; impact dosing; dosing fees; agonist treatment ... See more keywords
Commentary on ‘Opioid agonist treatment and patient outcomes during the COVID‐19 pandemic in south east Sydney, Australia’
Sign Up to like & getrecommendations! Published in 2022 at "Drug and Alcohol Review"
DOI: 10.1111/dar.13439
Abstract: Lintzeris et al. [1] provide the first analysis of changes to opioid agonist treatment (OAT) programs and patient outcomes in response to COVID-19 in New South Wales (NSW). We commend the authors for undertaking the… read more here.
Keywords: oat; number; covid pandemic; agonist treatment ... See more keywords
Informing youth-centred opioid agonist treatment: Findings from a retrospective chart review of youths' characteristics and patterns of opioid agonist treatment engagement in a novel integrated youth services program.
Sign Up to like & getrecommendations! Published in 2023 at "Early intervention in psychiatry"
DOI: 10.1111/eip.13446
Abstract: AIM Youth ages 12-24 account for approximately 20% of overdoses and yet are poorly reached by opioid agonist treatment (OAT), the most widely recommended treatment for opioid use disorder (OUD). This study contributes to understanding… read more here.
Keywords: youth; integrated youth; oat; agonist treatment ... See more keywords
Comparative effectiveness of urine drug screening strategies alongside opioid agonist treatment in British Columbia, Canada: a population-based observational study protocol
Sign Up to like & getrecommendations! Published in 2023 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-068729
Abstract: Introduction Urine drug tests (UDTs) are commonly used for monitoring opioid agonist treatment (OAT) responses, supporting the clinical decision for take-home doses and monitoring potential diversion. However, there is limited evidence supporting the utility of… read more here.
Keywords: british columbia; urine drug; agonist treatment; study ... See more keywords
Opioid use disorder in anaesthesia and intensive care: Prevention, diagnosis and management
Sign Up to like & getrecommendations! Published in 2022 at "Anaesthesia and Intensive Care"
DOI: 10.1177/0310057x211066929
Abstract: Opioid misuse is common, as is opioid agonist treatment of opioid dependence. Almost 3% of Australians and over 3.5% of those living in New Zealand report misuse of analgesics. Over 50,000 Australians receive opioid agonist… read more here.
Keywords: intensive care; management; care; agonist treatment ... See more keywords